首页|期刊导航|中国动物传染病学报|基于双抗体夹心ELISA检测PCV2疫苗的体外相对效力

基于双抗体夹心ELISA检测PCV2疫苗的体外相对效力OA

Detection of the Relative Potency of PCV2 Vaccine Based on Double Antibody Sandwich ELISA

中文摘要英文摘要

PCV2自发现以来给养猪业带来了巨大的经济损失.PCV2疫苗的推广和使用有效降低了 PCV2对养猪业的危害.目前市面上商品化PCV2疫苗种类多,效果参差不齐,为了更经济快速地评价和筛选PCV2疫苗,本研究建立了一种检测PCV2 Cap蛋白的双抗体夹心ELISA方法,并对16种市面上常见的PCV2商品化疫苗内的Cap蛋白抗原含量进行检测,从而检验疫苗的体外相对效力.结果表明:本方法适用于PCV2全病毒灭活苗、Cap蛋白亚单位疫苗、PCV2病毒样颗粒(virus-like particles,VLPs)疫苗的相对效力检验;PCV2疫苗体外相对效力差异较大,亚单位疫苗体外相对效力明显高于全病毒灭活苗.该体外相对效力检验方法可以缩减PCV2疫苗检验成本,提升检验效率,是动物体内效力检验方法的一种补充甚至替代方法,可用于PCV2疫苗的质量检测及,以及为猪场选择PCV2疫苗提供参考和指导.

PCV2 has caused huge economic losses to the pig industry since its discovery.The promotion and use of PCV2 vaccines have effectively reduced the harm of PCV2 to the pig industry.At present,there are many kinds of commercial PCV2 vaccines on the market,which show varying the immune effects.To evaluate and screen PCV2 vaccines more economically and quickly,a double antibody sandwich ELISA for detecting PCV2 cap protein was established in this study.The antigen content of cap protein in 16 common commercial PCV2 vaccines on the market was tested to evaluate the relative efficacy of the vaccine.The results showed that this method was suitable for testing the relative potency test of inactivated PCV2 whole virus vaccine,cap protein subunit vaccine and PCV2 virus-like particles(VLPs)vaccine.The relative potency of the subunit vaccine was significantly higher than that of the whole virus-inactivated vaccine.The relative potency test method reduced the cost of PCV2 vaccine testing and improves the efficiency.In summary,this method was a supplementary or even alternative method for the in vivo potency test,which may be used to determine for the of PCV2 vaccine potency and provide reference and guidance for the selection of a PCV2 vaccine on pig farms.

宁李纳;刘甜甜;凌同;李欣;陈志雄;范杰;王洪亮;葛猛

湖南农业大学动物医学院,长沙 410128湖南农业大学动物医学院,长沙 410128湖南中岸生物药业有限公司,长沙 410300湖南农业大学动物医学院,长沙 410128湖南农业大学动物医学院,长沙 410128湖南农业大学动物医学院,长沙 410128长沙市动植物疫病预防控制中心,长沙 410100湖南农业大学动物医学院,长沙 410128

农业科技

PCV2疫苗体外相对效力

PCV2vaccinerelative efficacy in vitro

《中国动物传染病学报》 2026 (3)

44-50,7

国家自然科学基金面上项目(32072871)湖南省重点研发计划项目(2023NK2017)云南省重大科技专项计划(202202AE090032)

评论